Bisdemethoxycurcumin inhibits Wnt/β-catenin pathway by increasing WIF-1 expression, which subsequently leads to suppression of TGF-β1-induced EMT migration. - GreenMedInfo Summary

Abstract Title:

Abstract Source:

Abstract Author(s):

Abstract:

Study Type : In Vitro Study
Additional Links
Substances : Bisdemethoxycurcumin : CK(35) : AC(19), Curcumin : CK(4844) : AC(2458)
Diseases : Carcinoma: Non-Small-Cell Lung : CK(264) : AC(161), Lung Cancer : CK(1741) : AC(742), Lung Cancer: Metastatic : CK(40) : AC(15)
Pharmacological Actions : Anti-metastatic : CK(1284) : AC(927), Wnt/β-catenin pathway down-regulation : CK(49) : AC(27)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Key Research Topics

Disease

Carcinoma: Non-Small-Cell Lung
Lung Cancer
Lung Cancer: Metastatic

Substance

Curcumin
Bisdemethoxycurcumin

Pharmacological Actions

Anti-metastatic
Wnt/β-catenin pathway down-regulation
Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.